These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2716670)

  • 1. Drug advertising.
    Moulds RF; Wing LM
    Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug advertising.
    Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical promotion.
    Harvey K
    Med J Aust; 1990 Jan; 152(2):57-8. PubMed ID: 2296230
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Assessment of advertising.
    Wigle WW
    Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical advertising: from prospectus to marketing.
    Cambronero-Saiz B
    J Epidemiol Community Health; 2007 Apr; 61(4):366. PubMed ID: 17372300
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug advertising.
    Bell KD
    Med J Aust; 1987 Oct; 147(7):361. PubMed ID: 3657662
    [No Abstract]   [Full Text] [Related]  

  • 7. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 8. Can drug companies have it both ways?
    Rapp MS
    CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
    [No Abstract]   [Full Text] [Related]  

  • 9. Capitol Hill panelists want FDA intervention in DTC drug advertising.
    Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177
    [No Abstract]   [Full Text] [Related]  

  • 10. US drug industry's guidelines on advertising too limited, say critics.
    Burton B
    BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug marketing practices criticized.
    Wagner L
    Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088
    [No Abstract]   [Full Text] [Related]  

  • 12. "Ethical" drugs.
    Rivin AU
    Pharos Alpha Omega Alpha Honor Med Soc; 1980; 43(2):9-10. PubMed ID: 7384207
    [No Abstract]   [Full Text] [Related]  

  • 13. PAAB: a lesson in self-government.
    Lexchin J
    CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug firms vow to tone down consumer advertisements.
    Wadman M
    Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559
    [No Abstract]   [Full Text] [Related]  

  • 15. Advertising standards.
    Drug Ther Bull; 2013 Jul; 51(7):73. PubMed ID: 23842632
    [No Abstract]   [Full Text] [Related]  

  • 16. Traveling medicine shows: a modern update?
    Carroll-Johnson RM
    Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666
    [No Abstract]   [Full Text] [Related]  

  • 17. New DTC guidelines please drug companies, anger critics.
    Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulating pharmaceutical advertising: what will work?
    Shapiro MF
    CMAJ; 1997 Feb; 156(3):359-61. PubMed ID: 9033416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Questions timing of publicity on new drug.
    Dorsey M
    J Am Vet Med Assoc; 1999 Mar; 214(5):623-4. PubMed ID: 10088006
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug ads: how much is hype?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):1-2. PubMed ID: 11682901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.